Home/Pipeline/FORTIFY TRG® Tissue Repair Graft

FORTIFY TRG® Tissue Repair Graft

Soft Tissue Repair

Approved/CommercialMarketed

Key Facts

Indication

Soft Tissue Repair

Phase

Approved/Commercial

Status

Marketed

Company

Sanara MedTech

About Sanara MedTech

Sanara MedTech is a Texas-based medical technology company with a mission to improve clinical outcomes and reduce healthcare expenditures through transformative surgical and wound care products. The company has successfully commercialized a portfolio of regenerative medicine products for soft tissue repair and surgical site management, establishing a revenue-generating foundation. Its strategic focus is now on advancing its flagship OsStic™ bone bioadhesive technology, a high-potential platform with FDA Breakthrough Device Designation, while leveraging its commercial infrastructure for growth.

View full company profile

Therapeutic Areas

Surgical/Wound Management Orthopedic Trauma Bone Repair

Other Soft Tissue Repair Drugs

Drug	Company	Phase	Status
Renaparin®	Corline Biomedical	Preclinical	Partnering
CHC™	Corline Biomedical	Research	Platform Expansion
Rotium Bioresorbable Wick	Nanofiber Solutions	Commercial	Active
FORTIFY FLOWABLE® Extracellular Matrix	Sanara MedTech	Approved/Commercial	Marketed